Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents

Author(s): S. Theocharis, A. Margeli, G. Kouraklis

Journal Name: Current Medicinal Chemistry - Anti-Cancer Agents
Continued as Anti-Cancer Agents in Medicinal Chemistry

Volume 3 , Issue 3 , 2003


The Peroxisome Proliferator Activated Receptors (PPARs) are initially described as molecular targets for compounds inducing peroxisome proliferation. Among the three PPAR subtypes (alpha, beta, gamma), PPAR-gamma acting as a ligand-activated transcription factor, proved to be an important regulator of adipogenic differentiation and glucose homeostasis. Recent data support evidence for participation of PPAR-gamma, upon ligands activation, in the biological mechanisms underlying the carcinogenic evolution. Specific PPAR-gamma ligands affect cancer cells proliferation and differentiation acting as cell cycle modulators, suggesting their use as an important tool for future therapeutic approach in cancer. In this review, the latest knowledge on PPAR-gamma activation and molecular mechanisms of PPAR-gamma ligands mediated anti-tumoral activity are presented. In vitro and in vivo studies concerning the use of PPAR-gamma ligands in different cancer types are also included.

Keywords: ppar-gamma, ligands, cancer, treatment, cell cycle related molecules

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [239 - 251]
Pages: 13
DOI: 10.2174/1568011033482431
Price: $65

Article Metrics

PDF: 1